In this video, Dr. Paz-Ares discusses a phase III study that showed that nivolumab improved survival and response rates in previously treated patients with metastatic non-squamous non-small-cell lung cancer (NSCLC).
Luis Paz-Ares, MD
Advertisement
Articles by Luis Paz-Ares, MD
Advertisement
Latest Updated Articles
Nivolumab Effective in Advanced Non-Squamous NSCLCPublished: June 10th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
FDA Issues CRL for Dasatinib in CML/ALL
5
